Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3 in the page footer. This reflects a newer UI/system update to the record history page.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRecruitment is now closed (no longer looking for participants) and the record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.3%

- Check28 days agoChange DetectedA new revision label 'Revision: v3.5.5' was added to the page history. The previous label 'Revision: v3.5.4' was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.5.4 has been added to the Study Record Versions, and the previous revision v3.5.3 has been removed from the history. This updates the revision history to reflect the latest submission.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page’s revision label updates from “v3.5.2” to “v3.5.3,” reflecting a change in the site’s display/versioning rather than the underlying study record.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.